Sector
Pharma & Biotech
![Novartis v. Natco imparts clarity on examination and opposition process under Patents Act being parallel but independent](/storage/media/image/article/681a23b0649e61ca572cb5bb8db206ec/banner/3ce6d3c8830d27ec2e6a1936ecbaa514/conversions/Pharma-online-hal-gatewood-iPl3q-gEGzY-unsplash-medium.jpg)
Novartis v. Natco imparts clarity on examination and opposition process under Patents Act being para...
31 May 2024In a decision dated January 9, 2024, the Delhi High Court clarified that the examination and opposition process, though statutorily structured to proceed parallelly, are independent and separate.
![What should we know about the names of drugs?](/storage/media/image/article/05b0afd266cc205432b8dad3f3413c28/banner/c4b43ae017af4001c5193d310bf00942/conversions/iStock-1458808901-medium.jpg)
What should we know about the names of drugs?
31 May 2024When it comes to naming drugs, there’s more to consider than simply coming up with a snappy trade name. Ling Zhao and Qin Li explain how to navigate the three types of commercial identification of pharmaceuticals: the generic name, the trade name and...
![Method of diagnosis and patentability in India](/storage/media/image/article/2548a4ac7ad6eddd035bced24ec6d964/banner/019f8b946a256d9357eadc5ace2c8678/conversions/iStock-1319031310-medium.jpg)
Method of diagnosis and patentability in India
30 November 2023The Chinese University of Hong Kong and Sequenom, Inc. (the appellants) filed an appeal on October 12, 2023, with the High Court of Madras, praying the court to set aside the order dated March 31, 2021, passed by the respondent (the Indian Patent Off...
![2023 India’s Top IP Firms and Practices Revealed](/storage/media/image/article/a10a26631d45928cb8be4ebabbee8b8d/banner/b922ede9c9eb9eabec1c1fecbdecb45d/conversions/banner-medium.jpg)
2023 India’s Top IP Firms and Practices Revealed
07 November 2023Intellectual property owners have been overwhelmingly positive about the changes they’ve seen to India’s IP regime over recent years. The country has consistently updated its IP laws and aggressively worked to reduce the time it takes to move an acti...
![Contemnor to pay Rs20 million to Pfizer in Indian patent infringement case](/storage/media/image/article/04da4aea8e38ac933ab23cb2389dddef/banner/a8345c3bb9e3896ea538ce77ffaf2c20/conversions/Pfizer-Banner--medium.jpg)
Contemnor to pay Rs20 million to Pfizer in Indian patent infringement case
27 February 2023Pfizer Inc. and its group companies filed a suit bearing no. CS (COMM) No. 442 of 2021 titled as Pfizer Inc. & Ors. v. Triveni Interchem Private Limited & Ors. before the Delhi High Court for infringement of patent IN 218291 for the compound palbocic...